Diagnostic Companies Aim to Bring Routine Testing to Point of Care, but Face Significant Hurdles

NEW YORK – Some five years after the collapse of Theranos, a handful of diagnostic companies are once again trying to bring routine clinical testing to the point of care…

Read the full article here.